Skip to main content
. 2020 May 4;10(5):48. doi: 10.1038/s41408-020-0318-1

Fig. 4. TKI efficacy by ELN criteria.

Fig. 4

Overall survival in patients treated with higher intensity chemotherapy by TKI use within ELN 2017 risk categories, (a) favorable (b) intermediate (c) unfavorable.